ENVESTNET ASSET MANAGEMENT INC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,589,910
+342.7%
82,413
+267.2%
0.00%
Q2 2023$810,938
+9.4%
22,445
+12.5%
0.00%
Q1 2023$741,481
-1.5%
19,943
+20.0%
0.00%
Q4 2022$752,962
-29.0%
16,618
+9.3%
0.00%
-100.0%
Q3 2022$1,061,000
+11.9%
15,199
+7.6%
0.00%0.0%
Q2 2022$948,000
+43.0%
14,124
+75.1%
0.00%
Q1 2022$663,000
+208.4%
8,068
+565.1%
0.00%
Q3 2021$215,000
-21.2%
1,213
-23.9%
0.00%
Q1 2021$273,000
-9.6%
1,593
+15.9%
0.00%
Q4 2020$302,000
-5.6%
1,374
-28.7%
0.00%
Q3 2020$320,0001,9260.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$688,784,00067.42%
Avoro Capital Advisors LLC 4,535,000$996,067,00017.15%
Darwin Global Management, Ltd. 260,876$57,299,00015.99%
Boxer Capital, LLC 1,765,560$387,788,00012.46%
Perceptive Advisors 3,693,516$811,244,0008.71%
Consonance Capital Management LP 330,000$72,481,0006.77%
EcoR1 Capital, LLC 464,298$101,978,0005.48%
Fairmount Funds Management LLC 60,500$13,288,0004.75%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 67,400$14,804,0004.04%
RTW INVESTMENTS, LP 1,054,364$231,581,0003.88%
View complete list of MIRATI THERAPEUTICS INC shareholders